Next-Generation Organoid Scan: Automated Platform for 3D Imaging and Electrochemical Sensing for Organoid Drug Response Analysis

PI

Nicholas J. Durr, Ph.D.

Nicholas J. Durr, Ph.D.

Department of Biomedical Engineering
Johns Hopkins University

Next-Generation Organoid Scan: Automated Platform for 3D Imaging and Electrochemical Sensing for Organoid Drug Response Analysis Medical Devices & Biomaterials

Project Summary

Automated, high-throughput system for real-time 3D imaging and analysis of organoids in drug screening, enhancing precision and depth.

Final Goal (Expected Outcomes)

  1. Prototype Development (automated drug screening, real-time, large-area, high-resolution 2D/3D imaging system)
  2. Real-time Imaging-based Drug Response Analysis Program (real-time analysis of drug interactions using the imaging data obtained)
  3. Reliability Evaluation by Users (to evaluate the system’s reliability across various drug screening protocols)
  4. Desired Company Evaluation (Present the system to potential industry partners and stakeholders for evaluation)
  5. Regulatory and Compliance Preparation (Adjust system specifications based on regulatory feedback)